Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-99
SponsorSalem Anaesthesia Pain Clinic

About this trial

Prospective observational crossover study of 150 consenting adult patients who are undergoing chronic pain management. For insomnia treatment, each patient ingests prescribed doses of Lemborexant or Zopiclone or Clonidine on alternate nights. Each patient uses a special validated sleep diary to collect data including pain score, sleep score, sleep duration, sleep medication type, and adverse effects. Each patient completes the diary for 3 continuous weeks. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.

Eligibility criteria

Qualifiers

adult chronic pain patients

good treatment compliance

severe chronic insomnia

failure of non-pharmacologic sleep therapy

Disqualifiers

obstructive sleep apnoea

body mass index (BMI) ≥40

organ insufficiency

cognitive disorder

Trial design

Treatments tested in this trial

  • Lemborexant

Treatment groups

No treatment groups listed

Sponsors and collaborators